ReviewExpert opinion on therapeutic targets

Powering down the mitochondrial LonP1 protease: a novel strategy for anticancer therapeutics.

Rahul Shetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.